تأثیر تمرینات هوازی و مقاومتی بر برخی سایتوکین‌ها در بیماران مبتلا به کبد چرب غیر الکلی، مرور سیستماتیک و فراتحلیل

##Afsordeh, K., et al. (2019). "Effect of aerobic training and vitamin D supplements on fatty liver and lipid profiles in women with fatty liver."  43(1): 8-14.##Armstrong, M. J., et al. (2014). "Extrahepatic complications of nonalcoholic fatty liver disease." Hepatology 59(3): 1174-1197. ##Bahcecioglu, I. H., et al. (2005). "Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis." Hepato-gastroenterology 52(65): 1549-1553. ##Bashiri, J., et al. (2010). "Effect of concurrent creatine monohydrate ingestion and resistance training on hepatic enzymes activity levels in non-athlete males." Iranian Journal of Endocrinology and Metabolism 12(1): 42-47. ##Boström, P., et al. (2012). "A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis."  481(7382): 463-468. ##Cerqueira, É., et al. (2020). "Inflammatory effects of high and moderate intensity exercise—a systematic review." Frontiers in physiology 10: 1550. ##Cheraghpour, M., et al. (2013). "The relationship between the immune system and the inflammatory mechanisms in obesity with insulin resistance." Iranian Journal of Nutrition Sciences & Food Technology 7(5). ##de Piano, A., et al. (2012). "Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents." Eur J Gastroenterol Hepatol 24(11): 1313-1324. ##Edmison, J. and A. J. McCullough (2007). "Pathogenesis of non-alcoholic steatohepatitis: human data." Clin Liver Dis 11(1): 75-104, ix. ##Fadaei, F., et al. (2021). "The effect of 5 weeks of high-intensity interval training on the serum levels of Resistin and adiponectin in Wistar rats with nonalcoholic fatty liver." Tehran University Medical Journal TUMS Publications 79(3): 240-247. ##Fealy, C. E., et al. (2012). "Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease." J Appl Physiol (1985) 113(1): 1-6. ##Fontes-Cal, T. C., et al. (2021). "Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression." Frontiers in Immunology 12: 708959. ##Ghasemalipour, H., et al. (2015). "The Effect of Regular Aerobic Training on Tumor Necrosis Factor-Alpha (TNF-α) in Males With Type II Diabetes." Avicenna Journal of Medical Biochemistry 3(1): 4-26908. ##Glass, O., et al. (2018). "Serum Interleukin‐8, osteopontin, and monocyte chemoattractant protein 1 are associated with hepatic fibrosis in patients with nonalcoholic fatty liver disease." Hepatology Communications 2(11): 1344-1355. ##Glass, O. K., et al. (2017). "Exercise training as treatment of nonalcoholic fatty liver disease." Journal of Functional Morphology and Kinesiology 2(4): 35. ##Gutin, B. and S. Owens (1999). "Role of exercise intervention in improving body fat distribution and risk profile in children." Am J Hum Biol 11(2): 237-247. ##Guturu, P. and A. Duchini (2012). "Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity." International journal of hepatology 2012. ##Hallsworth, K., et al. (2011). "Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss." Gut 60(9): 1278-1283. ##Hashida, R., et al. (2017). "Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review." J Hepatol 66(1): 142-152. ##Hickman, I. J., et al. (2013). "A pilot randomised study of the metabolic and histological effects of exercise in non-alcoholic steatohepatitis." Journal of Diabetes & Metabolism 4(8): 1-10. ##Houghton, D., et al. (2017). "Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial." Clinical Gastroenterology and Hepatology 15(1): 96-102. e103. ##Iwanaga, S., et al. (2020). "Hybrid Training System Improves Insulin Resistance in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study." The Tohoku Journal of Experimental Medicine 252(1): 23-32. ##Kawaguchi, T., et al. (2011). "Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study." J Gastroenterol 46(6): 746-757. ##Keating, S. E., et al. (2015). "Effect of aerobic exercise training dose on liver fat and visceral adiposity." Journal of hepatology 63(1): 174-182. ##Kim, D., et al. (2016). "Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease." Clinical Gastroenterology and Hepatology 14(1): 132-138. e134. ##Kim, D. and W. R. Kim (2017). "Nonobese fatty liver disease." Clinical Gastroenterology and Hepatology 15(4): 474-485. ##Kim, H. J., et al. (2004). "Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults." Archives of internal medicine 164(19): 2169-2175. ##Koehler, E. M., et al. (2012). "Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study." Journal of hepatology 57(6): 1305-1311. ##Larson‐Meyer, D. E., et al. (2008). "Effect of 6‐month calorie restriction and exercise on serum and liver lipids and markers of liver function." Obesity 16(6): 1355-1362. ##Lazo, M., et al. (2010). "Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes." Diabetes care 33(10): 2156-2163. ##Levinger, I., et al. (2009). "Inflammation, hepatic enzymes and resistance training in individuals with metabolic risk factors." Diabetic medicine 26(3): 220-227. ##Mahmoudi, A., et al. (2019). "The Effect of Running on a Treadmill and Low Calorie Diet on Visfatin and hs-CRP Values in People with Non-Alcoholic Fatty Liver Disease." Journal of Ardabil University of Medical Sciences 19(1): 20-29. ##Moosavi-Sohroforouzani, A. and M. Ganbarzadeh (2016). "Reviewing the physiological effects of aerobic and resistance training on insulin resistance and some biomarkers in non-alcoholic fatty liver disease." KAUMS Journal (FEYZ) 20(3): 282-296. ##Motamed, N., et al. (2020). "The incidence and risk factors of non-alcoholic fatty liver disease: A cohort study from Iran."  20(2). ##Mozaffari-Khosravi, H., et al. (2011). "The Effect a Single Mega Dose of Vitamin D on Pro-inflammatory Factors in Mothers with Gestational Diabetes Mellitus after Delivery." SSU_Journals 19(2): 242-256. ##Nath, P., et al. (2020). "Effect of Exercise on NAFLD and Its Risk Factors: Comparison of Moderate versus Low Intensity Exercise." J Clin Transl Hepatol 8(2): 120-126. ##Nayebifar, S., et al. (2011). "The effect of aerobic and resistance trainings on serum C-Reactive Protein, lipid profile and body composition in overweight women." Modern Care Journal 8(4). ##Norton, K., et al. (2010). "Position statement on physical activity and exercise intensity terminology." J Sci Med Sport 13(5): 496-502. ##Orci, L. A., et al. (2016). "Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression." Clin Gastroenterol Hepatol 14(10): 1398-1411. ##Paschos, P. and K. Paletas (2009). "Non alcoholic fatty liver disease and metabolic syndrome." Hippokratia 13(1): 9. ##Pedersen, B. K. and C. P. Fischer (2007). "Beneficial health effects of exercise–the role of IL-6 as a myokine." Trends in pharmacological sciences 28(4): 152-156. ##Pedersen, L., et al. (2011). "Exercise‐induced liver chemokine CXCL‐1 expression is linked to muscle‐derived interleukin‐6 expression." The Journal of physiology 589(6): 1409-1420. ##Pugh, C. J., et al. (2014). "Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease." Am J Physiol Heart Circ Physiol 307(9): H1298-1306. ##Rezende, R. E., et al. (2016). "Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease." Menopause 23(8): 876-883. ##Santos, A. R. d. O. d., et al. (2021). "Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions." International Journal of Molecular Sciences 22(5): 2639. ##Shetty, G. K., et al. (2004). "Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes." Diabetes care 27(10): 2450-2457. ##Somi, M. H., et al. (2017). "Determine effect of weight loss on serum level of inflammatory cytokines IL-1β, IL-6, CRP andTNF-α in obese patients with fatty liver disease." Medical Journal of Tabriz University of Medical Sciences 39(3): 61-69. ##Straznicky, N., et al. (2012). "The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects." Diabetes, Obesity and Metabolism 14(2): 139-148. ##Taheri Kalani, A. and M. Nikseresht (2015). "The effect of 10 weeks resistance and aerobic training on inflammatory cytokines in sedentary overweight men." scientific journal of ilam university of medical sciences 23(5): 17-26. ##Takahashi, H., et al. (2018). "Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms." Front Endocrinol (Lausanne) 9: 588. ##Targher, G., et al. (2010). "Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease." New England Journal of Medicine 363(14): 1341-1350. ##Thompson, D., et al. (2010). "Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged men: a randomized-controlled trial." Journal of applied physiology 108(4): 769-779. ##Tofighi, A. (2010). "Impact of water training on serum adiponectin level and insulin resistance in obese postmenopausal women." Iranian Journal of Endocrinology and Metabolism 12(3): 260-315. ##van der Windt, D. J., et al. (2018). "The Effects of Physical Exercise on Fatty Liver Disease." Gene Expr 18(2): 89-101. ##Younossi, Z. M., et al. (2016). "Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes." Hepatology 64(1): 73-84. ##Younossi, Z. M., et al. (2011). "Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008."  9(6): 524-530. e521. ##Zelber‐Sagi, S., et al. (2008). "Role of leisure‐time physical activity in nonalcoholic fatty liver disease: a population‐based study." Hepatology 48(6): 1791-1798. ##Zimmermann, H. W., et al. (2011). "Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis." PloS one 6(6): e21381. ##